The analysis indicates a bearish outlook for UnitedHealth Group (UNH). Short-term and long-term moving averages suggest selling pressure, with a recent 3-month MACD sell signal. Volume has decreased, reducing overall risk. Technical analysis points to resistance at $336.50 and $352.31, with support at $308.49. Analysts have a mixed view, with some giving a 'buy' rating based on positive growth prospects, while others are cautious due to recent performance and market conditions. The stock is currently trading at a P/E ratio of 16.60, considered potentially undervalued. Recent insider trading activity shows a net buying trend, with several purchases noted.